Shareholders’ Equity (Tables)

6 Months Ended

Jun. 30, 2025

Schedule of Stock-based Compensation Expense

The Company recognized stock-based compensation expense as follows (in thousands):


	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
Subscriber related	$	19	$	79	$	88	$	158
Sales and marketing	2,151		4,670		(1,050)		9,377
Technology and development	2,635		2,631		5,915		6,509
General and administrative	3,451		2,928		6,767		7,241
Total stock-based compensation expense	$	8,256	$	10,308	$	11,720	$	23,285

Schedule of of Stock Option Activity

A summary of time-based stock option activity for the six months ended June 30, 2025 is as follows (in thousands, except share and per share amounts):


	Number of Shares	Weighted Average Exercise Price		Total Intrinsic Value		Weighted Average Remaining Contractual Life (Years)
Outstanding as of December 31, 2024	10,196,232	$	6.13	$	1,036	4.4

Exercised	(2,151,631)	$	1.31
Forfeited or expired	(300)	$	9.98
Outstanding as of June 30, 2025	8,044,301	$	7.42	$	3,480	4.1

Options vested and exercisable as of June 30, 2025	7,726,114	$	7.66	$	2,894	4.4

A summary of activity under the 2020 Plan for market and service-based stock options for the six months ended June 30, 2025 is as follows (in thousands, except share and per share amounts):


	Number of Shares	Weighted Average Exercise Price		Total Intrinsic Value		Weighted Average Remaining Contractual Life (Years)
Outstanding as of December 31, 2024	4,453,297	$	12.75	$	—	2.7

Outstanding as of June 30, 2025	4,453,297	$	12.75	$	—	2.2

Options vested and exercisable as of June 30, 2025	3,994,964	$	11.96	$	—	2.1

Schedule of Nonvested Restricted Stock Units Activity

A summary of the Company’s time-based restricted stock unit activity during the six months ended June 30, 2025 is as follows:


	Number of Shares	Weighted Average Grant-Date Fair Value
Unvested at December 31, 2024	26,709,357	$	2.47
Granted	3,356,913	$	1.50
Vested	(1,089,843)	$	3.15
Forfeited or expired	(1,503,652)	$	2.69
Unvested at June 30, 2025	27,472,775	$	2.31

A summary of the Company’s performance-based restricted stock unit activity during the six months ended June 30, 2025 is as follows:


	Number of Shares	Weighted Average Grant-Date Fair Value
Unvested at December 31, 2024	3,031,828	$	5.61
Granted	1,263,273	$	3.01


Unvested at June 30, 2025	4,295,101	$	4.85

A summary of the Company’s market and service-based restricted stock unit activity during the six months ended June 30, 2025 is as follows:


	Number of Shares	Weighted Average Grant-Date Fair Value
Unvested at December 31, 2024	—	$	—
Granted	1,304,802	$	2.81


Unvested at June 30, 2025	1,304,802	$	2.81

Schedule of Outstanding Warrants

A summary of the Company’s outstanding warrants as of June 30, 2025, are presented below (in thousands, except number of shares and exercise price):


	Number of Shares	Weighted Average Exercise Price		Total Intrinsic Value		Weighted Average Remaining Contractual Life (Years)
Outstanding as of December 31, 2024	166,670	$	17.40	$	—	7.6


Forfeited or expired	(3)	$	133,500.00
Outstanding as of June 30, 2025	166,667	$	15.00	$	—	7.1